Locations:
Search
Approach could help clinicians identify patients at an increased risk of progression who could benefit from more aggressive treatment
Polygenic risk score could help predict who will develop this aggressive breast cancer
This rare disease usually manifests as a firm, painless mass that is growing
New guidelines offer insight into emerging therapies, dental issues and more
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy
Research demonstrates improved overall survival for patients receiving comprehensive treatment for breast cancer in addition to radiation or surgical intervention for brain cancer
Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’
Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates
Extent of baseline burden impacts progression-free and overall survival
Real-world study shows high response rates that are durable with commercial lisocabtagene maraleucel
Advertisement
Advertisement